Omega Fund Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.7M Hold
8,081,089
21.25% 2
2025
Q4
$72.4M Sell
8,081,089
-750,000
-8% -$4.65M 25.27% 1
2025
Q3
$32.7M Sell
8,831,089
-2,211,639
-20% -$6.03M 14.69% 5
2025
Q2
$21.5M Sell
11,042,728
-2,029,612
-16% -$4.23M 13.94% 4
2025
Q1
$23M Hold
13,072,340
13.58% 4
2024
Q4
$34.8M Hold
13,072,340
22.55% 2
2024
Q3
$29.9M Sell
13,072,340
-203,544
-2% -$621K 18.71% 2
2024
Q2
$38.8M Sell
13,275,884
-796,456
-6% -$2.43M 28.72% 1
2024
Q1
$51.2M Sell
14,072,340
-1,000,000
-7% -$1.92M 33.05% 1
2023
Q4
$22.8M Hold
15,072,340
18.44% 3
2023
Q3
$20.2M Hold
15,072,340
18.55% 2
2023
Q2
$27.1M Hold
15,072,340
15.2% 2
2023
Q1
$25M Hold
15,072,340
16.32% 2
2022
Q4
$28.9M Hold
15,072,340
9.75% 3
2022
Q3
$33.8M Sell
15,072,340
-175,000
-1% -$500K 12.36% 3
2022
Q2
$49.4M Sell
15,247,340
-7,710,000
-34% -$33.6M 15.77% 2
2022
Q1
$121M Hold
22,957,340
24.71% 1
2021
Q4
$195M Sell
22,957,340
-5,255,036
-19% -$48.3M 27.59% 1
2021
Q3
$280M Hold
28,212,376
31.46% 1
2021
Q2
$263M Hold
28,212,376
29.73% 1
2021
Q1
$295M Buy
+28,212,376
New +$315M 27.89% 1

Other funds holding NUVB

Omega Fund Management's NUVB Position: Q1 2026 in Review

Omega Fund Management held its Nuvation Bio (NUVB) position steady in Q1 2026 at 8,081,089 shares worth $34.7M. The position accounts for 21.25% of the portfolio, ranked #2.

Omega Fund Management first reported a position in NUVB in Q1 2021 and has held it in 21 quarters since. The position peaked at $295M in Q1 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Omega Fund Management held 8,081,089 shares of Nuvation Bio worth $34.7M as of Q1 2026.
  • Omega Fund Management left its Nuvation Bio share count unchanged in Q1 2026.
  • Nuvation Bio made up 21.25% of Omega Fund Management's portfolio in Q1 2026, its #2 holding.
  • Omega Fund Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 21 quarters since.
  • Omega Fund Management's Nuvation Bio position peaked at $295M in Q1 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Omega Fund Management's 13F filing for Q1 2026, filed 15 May 2026.